FMP
NASDAQ
23.53 USD
-0.27 (-1.15%)
Mr. Paul J. Sekhri M.Sc.
Healthcare
Biotechnology
https://www.vtvtherapeutics.com
NASDAQ
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approac...
0001641489
US9183852048
918385105
3980 Premier Drive
336 841 0300
US
16
Jul 30, 2015
0001641489
NASDAQ
Biotechnology
Healthcare
918385105
US9183852048
US
23.53
0.51
79.38k
57.25M
-
7.38-39.6
4.28
-
-
-
-
-2.42
-
https://www.vtvtherapeutics.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.